Key result
Type 2 diabetes linked to ~39% higher MI risk in NAFLD patients.
Why the study?
Does type 2 diabetes increase the risk of myocardial infarction, stroke, and cardiovascular death in adults with non-alcoholic fatty liver disease?
Cohort (n=1,057,775)
Yes
Does type 2 diabetes increase the risk of myocardial infarction, stroke, and cardiovascular death in adults with non-alcoholic fatty liver disease?
Answers are grounded in this paper and cite their sources.
In patients with NAFLD, the presence of type 2 diabetes significantly increases the long-term risk of myocardial infarction, stroke, and cardiovascular death, particularly among those with fewer conventional risk factors.
Introduction: A complex bidirectional association between type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD) has been linked to unfavourable metabolic profile and an increasing risk of cardiovascular disease (CVD). This study aimed to investigate long-term CVD outcomes in patients with NAFLD according to glycaemic status using a nationwide cohort of Korean adults. Methods: This longitudinal study included 1 057 775 patients with NAFLD, who had participated in the national health screening in 2009 from baseline to the date of diagnosis of myocardial infarction (MI), stroke and cardiovascular (CV) death or up to 2020 during a follow-up period of 11.3 years. The baseline glycaemic status was divided into three categories (normal fasting glucose (NFG), impaired fasting glucose (IFG) and T2D). Results: A total of 26 491 cases of MI, 55 791 cases of stroke and 11 147 cases of CV death were identified. After adjusting for possible covariates, participants with T2D had a higher risk of CVD, with HRs of 1.39 (95% CI 1.35 to 1.44) for MI, 1.39 (95% CI 1.36 to 1.42) for stroke and 1.46 (95% CI 1.39 to 1.52) for CV death, compared with those with NFG. The IFG group did not exhibit a significant increase in the risk of MI, stroke and CV death compared with the NFG group. The increased risk of CVD attributable to T2D was more profound among individuals with fewer conventional risk factors, including younger age, not obese and the absence of hypertension. Conclusion: T2D is associated with an increased risk of CVD and CV mortality in patients with NAFLD. These results suggest that the identification of T2D in individuals with NAFLD may help in the early prediction of future progression of CVD.
No takes yet. Share an insight, caveat, or question.
Roh et al. (2025) conducted a cohort in Non-alcoholic fatty liver disease (NAFLD) (n=1,057,775). Type 2 diabetes (T2D) vs. Normal fasting glucose (NFG) was evaluated on Myocardial infarction (MI) (HR 1.39, 95% CI 1.35-1.44). Among patients with NAFLD, type 2 diabetes was associated with an increased risk of myocardial infarction, stroke, and cardiovascular death.
Synapse has enriched 10 related papers. Consider them for comparative context: